1422. A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections

BACKGROUND: Multi-drug resistant (MDR) pathogens are a continuously evolving threat for which there are limited effective treatment modalities. Omadacycline (OMC) is a novel oral and intravenously administered aminomethylcycline with potent in-vitro activity against MDR gram-negative and gram-positi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghali, Amer El, Allosaimy, Sara, Morrisette, Taylor, Molina, Kyle C, Frens, Jeremy J, Stevens, Ryan W, Bouchard, Jeannette, Brandon Bookstaver, P, Veve, Michael P, Vemula, Raaga, Philley, Julie, Rebold, Nicholas S, Holger, Dana, Kunz Coyne, Ashlan J, Lagnf, Abdalhamid M, Lucas, Kristen, Witucki, Paige, Rybak, Michael J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752563/
http://dx.doi.org/10.1093/ofid/ofac492.1251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752563/
http://dx.doi.org/10.1093/ofid/ofac492.1251

Ejemplares similares